Page 323 - The Vasculitides, Volume 1: General Considerations and Systemic Vasculitis
P. 323

In: The Vasculitides, Volume 1               ISBN: 978-1-63463-110-5
Editors: David S. Younger       © 2015 Nova Science Publishers, Inc.

                                                                    Chapter 16

       Rheumatoid Arthritis Vasculitis

     Elana J. Bernstein, M.D., M.Sc. and Robert F. Spiera, M.D.?

     Scleroderma, Vasculitis & Myositis Center, Department of Medicine, Division of
            Rheumatology, The Hospital for Special Surgery, New York, NY, US

                                   Abstract

          Rheumatoid arthritis is a systemic autoimmune disease characterized by
     inflammatory synovitis. Rheumatoid vasculitis is suggested by the presence fever, weight
     loss, digital infarcts, deep cutaneous ulcers, mononeuritis multiplex, peripheral gangrene,
     and other extra-articular complications. It is confirmed by the presence of necrotizing
     arteritis in a biopsy of involved skin, nerve and muscle tissue. Accurately recognized and
     properly treated with immunosuppressant and biological therapies, rheumatoid vasculitis
     has an overall favorable prognosis. Thus, it is important to consider the diagnosis in all
     those so suspected. This chapter considers the epidemiology, clinical and laboratory
     manifestations, histopathology, and management of rheumatoid vasculitis.

                                Introduction

     Rheumatoid arthritis (RA) is a systemic autoimmune disease characterized by
inflammatory synovitis. An estimated 1,293,000 adults ? 18 years of age in the United States
have RA representing about 0.6% of the adult population. Rheumatoid arthritis vasculitis or
rheumatoid vasculitis (RV) is suggested by the presence fever, weight loss, digital infarcts,
deep cutaneous ulcers; mononeuritis multiplex (MNM), peripheral gangrene, and other extra-
articular complications extra-articular (ExRA) complications, including necrotizing vasculitis,
the initial histopathologic manifestations of which are generally found in a biopsy of skin,
nerve and muscle tissue in the majority of affected patients. While not strikingly different

? Correspondence: Robert F. Spiera M.D., Professor of Clinical Medicine, Director, Scleroderma, Vasculitis &
      Myositis Center, Department of Medicine/Division of Rheumatology, The Hospital for Special Surgery, 535
      East 70th Street, New York NY 10021. Email: [email protected],

            Complimentary Contributor Copy
   318   319   320   321   322   323   324   325   326   327   328